SLITRK4 and neoplasm: Finally, a small interfering RNA targeting SLITRK4 encapsulated into a lipid‐polymer hybrid nanoparticles platform (siSLITRK4‐NPs) significantly suppressed CRC tumor growth and liver metastasis.